• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏脂肪面积和皮下脂肪面积作为软组织肉瘤身体成分的测量指标。

Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma.

机构信息

Department of Surgery, Division of Surgical Oncology, University of California Davis, Sacramento, California, USA.

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

出版信息

J Surg Oncol. 2024 Sep;130(3):543-551. doi: 10.1002/jso.27751. Epub 2024 Jun 21.

DOI:10.1002/jso.27751
PMID:39402905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11753180/
Abstract

BACKGROUND AND OBJECTIVES

Soft tissue sarcomas (STS) are a heterogenous group of malignancies of mesenchymal origin. Given recent data linking obesity as well as the pattern of fat distribution with cancer outcomes, we sought to investigate the association of visceral fat area (VFA) and subcutaneous fat area (SFA) with oncologic outcomes in patients with STS undergoing surgery.

METHODS

We analyzed data from 88 patients with STS diagnosed from 2008 to 2022. Predictor variables included body mass index (BMI), VFA, and SFA. VFA and SFA were obtained from computed tomography of the abdomen and pelvis. Univariable and multivariable Cox regression analysis was used to analyze associations between predictor variables and overall survival and recurrence-free survival.

RESULTS

Although BMI was closely correlated with VFA (r = 0.69, p < 0.0001) and SFA (r = 0.80, p < 0.0001), there was no significant association between high BMI, VFA or SFA, and worse oncologic outcomes.

CONCLUSIONS

Although VFA and SFA are strongly correlated with BMI, we did not observe BMI nor imaging metrics of fat composition to be associated with worse oncologic outcomes. Further research is needed to elucidate any links between body fat content and metabolic or immune factors governing oncologic outcomes in STS.

摘要

背景与目的

软组织肉瘤(STS)是一种起源于间叶组织的异质性恶性肿瘤。鉴于最近的数据表明肥胖以及脂肪分布模式与癌症结局有关,我们试图研究内脏脂肪面积(VFA)和皮下脂肪面积(SFA)与接受手术治疗的 STS 患者的肿瘤学结局之间的关系。

方法

我们分析了 2008 年至 2022 年期间诊断为 STS 的 88 名患者的数据。预测变量包括体重指数(BMI)、VFA 和 SFA。VFA 和 SFA 是通过腹部和骨盆的计算机断层扫描获得的。单变量和多变量 Cox 回归分析用于分析预测变量与总生存和无复发生存之间的关系。

结果

尽管 BMI 与 VFA(r=0.69,p<0.0001)和 SFA(r=0.80,p<0.0001)密切相关,但高 BMI、VFA 或 SFA 与较差的肿瘤学结局之间没有显著关联。

结论

尽管 VFA 和 SFA 与 BMI 密切相关,但我们没有观察到 BMI 或脂肪成分的影像学指标与较差的肿瘤学结局相关。需要进一步研究阐明体内脂肪含量与代谢或免疫因素之间的任何联系,这些因素决定了 STS 的肿瘤学结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4900/11753180/d923cd40682a/nihms-2045571-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4900/11753180/14d9e25cc35d/nihms-2045571-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4900/11753180/54e205ea2d23/nihms-2045571-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4900/11753180/d923cd40682a/nihms-2045571-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4900/11753180/14d9e25cc35d/nihms-2045571-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4900/11753180/54e205ea2d23/nihms-2045571-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4900/11753180/d923cd40682a/nihms-2045571-f0003.jpg

相似文献

1
Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma.内脏脂肪面积和皮下脂肪面积作为软组织肉瘤身体成分的测量指标。
J Surg Oncol. 2024 Sep;130(3):543-551. doi: 10.1002/jso.27751. Epub 2024 Jun 21.
2
Visceral obesity is associated with outcomes of total mesorectal excision for rectal adenocarcinoma.内脏肥胖与直肠腺癌全直肠系膜切除术的结果有关。
J Surg Oncol. 2012 Mar 15;105(4):365-70. doi: 10.1002/jso.22031. Epub 2011 Jul 12.
3
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
4
Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy.在内脏与皮下脂肪比率增加的转移性黑色素瘤患者中,接受抗血管生成治疗后总生存期缩短。
Surg Oncol. 2015 Dec;24(4):353-8. doi: 10.1016/j.suronc.2015.09.002. Epub 2015 Oct 22.
5
Clinical Impact of Abdominal Fat Distribution on Prognosis After Esophagectomy for Esophageal Squamous Cell Carcinoma.腹部脂肪分布对食管鳞状细胞癌食管癌切除术后预后的临床影响
Ann Surg Oncol. 2016 Apr;23(4):1387-94. doi: 10.1245/s10434-015-5018-x. Epub 2015 Dec 14.
6
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer.内脏脂肪面积是一线贝伐珠单抗治疗转移性结直肠癌后结局的独立预测生物标志物。
Gut. 2010 Mar;59(3):341-7. doi: 10.1136/gut.2009.188946. Epub 2009 Oct 15.
7
Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects.内脏脂肪对肥胖日本受试者外周血细胞基因表达谱的影响。
Cardiovasc Diabetol. 2016 Nov 29;15(1):159. doi: 10.1186/s12933-016-0479-1.
8
High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes.高内脏脂肪与低皮下脂肪堆积作为2型糖尿病患者动脉粥样硬化的一个决定因素。
Cardiovasc Diabetol. 2015 Oct 7;14:136. doi: 10.1186/s12933-015-0302-4.
9
Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer.结直肠癌患者皮下和内脏脂肪肥胖的影响。
Clin Nutr. 2021 Nov;40(11):5631-5638. doi: 10.1016/j.clnu.2021.10.001. Epub 2021 Oct 11.
10
Visceral-to-subcutaneous fat ratio exhibits strongest association with early post-operative outcomes in patients undergoing surgery for advanced rectal cancer.内脏脂肪与皮下脂肪比率与接受先进直肠癌手术患者的术后早期结果具有最强相关性。
Int J Colorectal Dis. 2022 Aug;37(8):1893-1900. doi: 10.1007/s00384-022-04221-8. Epub 2022 Jul 28.

本文引用的文献

1
Imaging-based adipose biomarkers for predicting clinical outcomes of cancer patients treated with immune checkpoint inhibitors: a systematic review.基于成像的脂肪生物标志物预测接受免疫检查点抑制剂治疗的癌症患者的临床结局:一项系统综述
Front Oncol. 2023 Oct 17;13:1198723. doi: 10.3389/fonc.2023.1198723. eCollection 2023.
2
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer.三维 CT 扫描皮下脂肪和肌肉质量对免疫治疗癌症的协同预后价值。
J Immunother Cancer. 2023 Sep;11(9). doi: 10.1136/jitc-2023-007315.
3
Intratumoral NKp46 natural killer cells are spatially distanced from T and MHC-I cells with prognostic implications in soft tissue sarcoma.
肿瘤内 NKp46 自然杀伤细胞与 T 细胞和 MHC-I 细胞在空间上分离,这与软组织肉瘤的预后有关。
Front Immunol. 2023 Jul 21;14:1230534. doi: 10.3389/fimmu.2023.1230534. eCollection 2023.
4
Associations of subcutaneous fat area and Systemic Immune-inflammation Index with survival in patients with advanced gastric cancer receiving dual PD-1 and HER2 blockade.皮下脂肪面积和全身免疫炎症指数与接受双重 PD-1 和 HER2 阻断治疗的晚期胃癌患者生存的相关性。
J Immunother Cancer. 2023 Jun;11(6). doi: 10.1136/jitc-2023-007054.
5
Sarcopenia and frailty as predictors of surgical morbidity and oncologic outcomes in retroperitoneal sarcoma.肌肉减少症和虚弱作为预测腹膜后肉瘤手术发病率和肿瘤学结果的指标。
J Surg Oncol. 2023 Apr;127(5):855-861. doi: 10.1002/jso.27199. Epub 2023 Jan 9.
6
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.软组织肉瘤,第 2.2022 版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2022 Jul;20(7):815-833. doi: 10.6004/jnccn.2022.0035.
7
Association of Abdominal Visceral Adiposity and Total Fat Mass with Cancer Incidence and Mortality in White and Black Adults.腹部内脏脂肪堆积和总脂肪量与白人和黑人成年人的癌症发病率和死亡率的关联。
Cancer Epidemiol Biomarkers Prev. 2022 Aug 2;31(8):1532-1538. doi: 10.1158/1055-9965.EPI-22-0207.
8
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement.定义和诊断肌少症性肥胖的标准:ESPEN 和 EASO 共识声明。
Obes Facts. 2022;15(3):321-335. doi: 10.1159/000521241. Epub 2022 Feb 23.
9
Healthy US population reference values for CT visceral fat measurements and the impact of IV contrast, HU range, and spinal levels.美国健康人群 CT 内脏脂肪测量的参考值,以及静脉对比剂、HU 范围和脊柱水平的影响。
Sci Rep. 2022 Feb 11;12(1):2374. doi: 10.1038/s41598-022-06232-5.
10
Sex Differences of Visceral Fat Area and Visceral-to-Subcutaneous Fat Ratio for the Risk of Incident Type 2 Diabetes Mellitus.内脏脂肪面积和内脏-皮下脂肪比值的性别差异与 2 型糖尿病发病风险的关系。
Diabetes Metab J. 2022 May;46(3):486-498. doi: 10.4093/dmj.2021.0095. Epub 2021 Nov 18.